Insulin resistance in young type 1 diabetic patients

Diabetologia Doswiadczalna i Kliniczna

Volumn 6, Issue 6, 2006, Pages 293-298

  Szadkowska, Agnieszka ^a,c   Pietrzak, Iwona ^a   Bodalska Lipińska, Joanna ^b   Kuberska Kȩdzierska, Małgorzata ^b   Markuszewski, Leszek ^b   Bodalski, Jerzy ^a  

^a Klinika Chorób Dzieci Katedry Pediatrii Uniwersytetu Medycznego W odzi   (Poland)

^b Oddzial Kliniczny Kardiologii Interwencyjnej I Kardiodiabetologii Uniwersytetu Medycznego W Lodzi ^*

^c Klinika Chorob Dzieci I Katedry Pediatrii UM   (Poland)

Author keywords

Daily dose of insulin; Insulin resistance; Metabolic control; Obesity; Type 1 diabetes mellitus

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PARAMETER; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 33947302874     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. James PT. Obesity: the worldwide epidemic. Clin Dermatol 2004; 4: 276-280.
2. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004; 10: 2444-2449.
3. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 10: 1066-1076.
4. Koivisto VA, Stevens LK, Mattock M et al. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Diabetes Care 1996; 19: 689-697.
5. Martin F, Stock A. Insulin sensitivity and vascular disease in insulin dependent diabetes. Br Med J 1968; 2: 81-82.
6. Ekstrand AV, Groop P, Gronhagen-Riska C. Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant 1998; 13: 3079-3083.
7. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 1993; 8876: 883-887.
8. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates projections to the year 2010. Diabet Med 1997; suppl 5: S1-S85.
9. Szadkowska A, Czerniawska E, Bodalski J. Zapadalność na cukrzycȩ typu 1 wśród dzieci i młodzieży regionu łódzkiego w latach 1983-2000. Przegla̧d Pediatr 2003; 2: 173-176.
10. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 3: E214-E223.
11. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 3: 173-194.
12. Acerini CL, Cheetham TD, Edge JA, Dunger DB. Both insulin sensitivity and insulin clearance in children and young adults with type I (insulin-dependent) diabetes vary with growth hormone concentrations and with age. Diabetologia 2000; 1: 61-68.
13. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991; 2: 277-282.
14. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000; 49: 626-632.
15. Yki-Jarvinen H, Koivisto VA. Natural course of insulin resistance in type I diabetes. N Engl J Med 1986; 4: 224-230.
16. Szadkowska A, Pietrzak I, Zmyslowska A, Wyka K, Bodalski J. Insulinooporność u dzieci i młodzieży ze świeżo rozpoznana̧. cukrzyca̧ typu 1. Med Wieku Rozwoj 2003; 2: 181-191.
17. Zahorska-Markiewicz B. Otyłość. Poradnik dla lekarzy. Arch-Plus, Kraków 2002.
18. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 9497: 1640-1649.
19. Huang TT, Kempf AM, Strother ML et al. Overweight and components of the metabolic syndrome in college students. Diabetes Care 2004; 2: 3000-3001.
20. Lowry R, Galuska DA, Fulton JE, Wechsler H, Kann L, Collins JL. Physical activity, food choice, and weight management goals and practices among US college students. Am J Prev Med 2000; 1: 18-27.
21. Codner E, Barrera A, Mook-Kanamori D. et al. Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type 1 diabetes mellitus. Pediatr Diabetes 2004; 4: 182-189.
22. Noczynska A, Filipowski H, Wasikowa R. Is overweight in patients with type 1 diabetes in the puberty a problem? Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2003; 2: 89-92.
23. Sinaiko AR, Steinberger J, Moran A, Prineas RJ, Jacobs DR. Jr. Relation of insulin resistance to blood pressure in childhood. J Hypertens 2002; 3: 509-517.
24. Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med 2001; 10: 786-796.
25. Thorn LM, Forsblom C, Fagerudd J. et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 2005; 8: 2019-2024.
26. Baron AD, Laakso M, Brechtel G, Edelman SV. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 1991; 3: 637-643.
27. Czyżyk A. Patofizjologia i klinika cukrzycy. Wydawnictwo Naukowe PWN, Warszawa 1997: 134-302.
28. Kahn SE, Prigeon RL, McCulloch DK, Bojko EJ, Bergman RN, Schwartz MW. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 11: 1663-1672.
29. Sarioglu B, Ozerkan E, Can S, Yaprak I, Topcuoglu R. Insulin secretion and insulin resistance determined by euglycemic clamp. J Pediatr Endocrinol Metab 1998; 1: 27-33.
30. Balkau B, Tichet J, Caces E, Vol S, Eschwege E, Cahane M. Insulin dose and cardiovascular risk factors in type 1 diabetic children and adolescents. Diabetes Metab 1998; 2: 143-150.
31. Reinehr T, Holl RW, Roth CL et al. Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. Pediatr Diabetes 2005; 1: 5-12.
32. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes mellitus and insulin resistance: A randomised controlled trial. Diabetes Care 2003; 1: 138-143.